VRC-FLUDNA057-00-VP

influenza A/H1 DNA vaccine · National Institute of Allergy and Infectious Diseases (NIAID), NIH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC-FLUDNA057-00-VP, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years Old [Phase 1]

See pricing